What is the current valuation of the Transgenic Animals Market?

The Transgenic Animals Market was valued at 3.56 USD Billion in 2024. Read More

What is the projected market size for the Transgenic Animals Market by 2035?

The market is projected to reach 10.66 USD Billion by 2035. Read More

What is the expected CAGR for the Transgenic Animals Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 10.48%. Read More

Which companies are considered key players in the Transgenic Animals Market?

Key players include Heska Corporation, Genus plc, and Novartis AG, among others. Read More

What are the primary applications of transgenic animals in the market?

Applications include recombinant human proteins, monoclonal antibodies, and xenotransplantation. Read More

What techniques are commonly used in the production of transgenic animals?

Common techniques include retro-virus-mediated transfer of gene and microinjection of DNA. Read More

Which model organisms dominate the Transgenic Animals Market?

Mice and rats are the dominant model organisms, with projected valuations of 4.5 and 2.4 USD Billion, respectively. Read More

What are the main end-user segments in the Transgenic Animals Market?

End-users include the biotechnological industry, research organizations, and academic institutes. Read More

How does the market for transgenic animals compare across different techniques?

The microinjection technique is projected to grow from 1.6 to 4.84 USD Billion during the forecast period. Read More

What is the significance of the biotechnological industry in the Transgenic Animals Market?

The biotechnological industry is expected to grow from 1.78 to 5.25 USD Billion, indicating its crucial role in market expansion. Read More

Transgenic Animals Market

ID: MRFR/LS/4018-HCR

110 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Transgenic Animals Market Research Report by Products (Gene Gun, Microinjection), Techniques (DNA Microinjection), Consumables (Probes), Application (Monoclonal Abs), Transgenic Animals (Mice) End User (Biotech Industries) - Forecast till 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Type (USD Billion)
  1. 4.1.1 OCR gene gun
  2. 4.1.2 microinjections
  3. 4.1.3 electroporator
2. 4.2 Healthcare, BY Techniques (USD Billion)
  1. 4.2.1 retro-virus-mediated transfer of gene
  2. 4.2.2 embryonic stem cell-mediated transfer of gene
  3. 4.2.3 microinjection of DNA
3. 4.3 Healthcare, BY Applications (USD Billion)
  1. 4.3.1 recombinant human proteins
  2. 4.3.2 monoclonal antibodies
  3. 4.3.3 xenotransplantation
4. 4.4 Healthcare, BY Model Organisms (USD Billion)
5. 4.5 Healthcare, BY End-Users (USD Billion)
  1. 4.5.1 biotechnological industry
  2. 4.5.2 research organizations
  3. 4.5.3 academic institutes
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Heska Corporation (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Genus plc (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Auburn University (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Transgenic Animal Production (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Recombinetics, Inc. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 University of California (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Horizon Discovery Group plc (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kymab Limited (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Novartis AG (CH)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TYPE
4. 6.4 US MARKET ANALYSIS BY TECHNIQUES
5. 6.5 US MARKET ANALYSIS BY APPLICATIONS
6. 6.6 US MARKET ANALYSIS BY MODEL ORGANISMS
7. 6.7 US MARKET ANALYSIS BY END-USERS
8. 6.8 CANADA MARKET ANALYSIS BY TYPE
9. 6.9 CANADA MARKET ANALYSIS BY TECHNIQUES
10. 6.10 CANADA MARKET ANALYSIS BY APPLICATIONS
11. 6.11 CANADA MARKET ANALYSIS BY MODEL ORGANISMS
12. 6.12 CANADA MARKET ANALYSIS BY END-USERS
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY TECHNIQUES
16. 6.16 GERMANY MARKET ANALYSIS BY APPLICATIONS
17. 6.17 GERMANY MARKET ANALYSIS BY MODEL ORGANISMS
18. 6.18 GERMANY MARKET ANALYSIS BY END-USERS
19. 6.19 UK MARKET ANALYSIS BY TYPE
20. 6.20 UK MARKET ANALYSIS BY TECHNIQUES
21. 6.21 UK MARKET ANALYSIS BY APPLICATIONS
22. 6.22 UK MARKET ANALYSIS BY MODEL ORGANISMS
23. 6.23 UK MARKET ANALYSIS BY END-USERS
24. 6.24 FRANCE MARKET ANALYSIS BY TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY TECHNIQUES
26. 6.26 FRANCE MARKET ANALYSIS BY APPLICATIONS
27. 6.27 FRANCE MARKET ANALYSIS BY MODEL ORGANISMS
28. 6.28 FRANCE MARKET ANALYSIS BY END-USERS
29. 6.29 RUSSIA MARKET ANALYSIS BY TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY TECHNIQUES
31. 6.31 RUSSIA MARKET ANALYSIS BY APPLICATIONS
32. 6.32 RUSSIA MARKET ANALYSIS BY MODEL ORGANISMS
33. 6.33 RUSSIA MARKET ANALYSIS BY END-USERS
34. 6.34 ITALY MARKET ANALYSIS BY TYPE
35. 6.35 ITALY MARKET ANALYSIS BY TECHNIQUES
36. 6.36 ITALY MARKET ANALYSIS BY APPLICATIONS
37. 6.37 ITALY MARKET ANALYSIS BY MODEL ORGANISMS
38. 6.38 ITALY MARKET ANALYSIS BY END-USERS
39. 6.39 SPAIN MARKET ANALYSIS BY TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY TECHNIQUES
41. 6.41 SPAIN MARKET ANALYSIS BY APPLICATIONS
42. 6.42 SPAIN MARKET ANALYSIS BY MODEL ORGANISMS
43. 6.43 SPAIN MARKET ANALYSIS BY END-USERS
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY TECHNIQUES
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY APPLICATIONS
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY MODEL ORGANISMS
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY END-USERS
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY TYPE
51. 6.51 CHINA MARKET ANALYSIS BY TECHNIQUES
52. 6.52 CHINA MARKET ANALYSIS BY APPLICATIONS
53. 6.53 CHINA MARKET ANALYSIS BY MODEL ORGANISMS
54. 6.54 CHINA MARKET ANALYSIS BY END-USERS
55. 6.55 INDIA MARKET ANALYSIS BY TYPE
56. 6.56 INDIA MARKET ANALYSIS BY TECHNIQUES
57. 6.57 INDIA MARKET ANALYSIS BY APPLICATIONS
58. 6.58 INDIA MARKET ANALYSIS BY MODEL ORGANISMS
59. 6.59 INDIA MARKET ANALYSIS BY END-USERS
60. 6.60 JAPAN MARKET ANALYSIS BY TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY TECHNIQUES
62. 6.62 JAPAN MARKET ANALYSIS BY APPLICATIONS
63. 6.63 JAPAN MARKET ANALYSIS BY MODEL ORGANISMS
64. 6.64 JAPAN MARKET ANALYSIS BY END-USERS
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUES
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY APPLICATIONS
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY MODEL ORGANISMS
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY END-USERS
70. 6.70 MALAYSIA MARKET ANALYSIS BY TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY TECHNIQUES
72. 6.72 MALAYSIA MARKET ANALYSIS BY APPLICATIONS
73. 6.73 MALAYSIA MARKET ANALYSIS BY MODEL ORGANISMS
74. 6.74 MALAYSIA MARKET ANALYSIS BY END-USERS
75. 6.75 THAILAND MARKET ANALYSIS BY TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY TECHNIQUES
77. 6.77 THAILAND MARKET ANALYSIS BY APPLICATIONS
78. 6.78 THAILAND MARKET ANALYSIS BY MODEL ORGANISMS
79. 6.79 THAILAND MARKET ANALYSIS BY END-USERS
80. 6.80 INDONESIA MARKET ANALYSIS BY TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY TECHNIQUES
82. 6.82 INDONESIA MARKET ANALYSIS BY APPLICATIONS
83. 6.83 INDONESIA MARKET ANALYSIS BY MODEL ORGANISMS
84. 6.84 INDONESIA MARKET ANALYSIS BY END-USERS
85. 6.85 REST OF APAC MARKET ANALYSIS BY TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY TECHNIQUES
87. 6.87 REST OF APAC MARKET ANALYSIS BY APPLICATIONS
88. 6.88 REST OF APAC MARKET ANALYSIS BY MODEL ORGANISMS
89. 6.89 REST OF APAC MARKET ANALYSIS BY END-USERS
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY TECHNIQUES
93. 6.93 BRAZIL MARKET ANALYSIS BY APPLICATIONS
94. 6.94 BRAZIL MARKET ANALYSIS BY MODEL ORGANISMS
95. 6.95 BRAZIL MARKET ANALYSIS BY END-USERS
96. 6.96 MEXICO MARKET ANALYSIS BY TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY TECHNIQUES
98. 6.98 MEXICO MARKET ANALYSIS BY APPLICATIONS
99. 6.99 MEXICO MARKET ANALYSIS BY MODEL ORGANISMS
100. 6.100 MEXICO MARKET ANALYSIS BY END-USERS
101. 6.101 ARGENTINA MARKET ANALYSIS BY TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY TECHNIQUES
103. 6.103 ARGENTINA MARKET ANALYSIS BY APPLICATIONS
104. 6.104 ARGENTINA MARKET ANALYSIS BY MODEL ORGANISMS
105. 6.105 ARGENTINA MARKET ANALYSIS BY END-USERS
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUES
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATIONS
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY MODEL ORGANISMS
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USERS
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY TECHNIQUES
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY APPLICATIONS
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY MODEL ORGANISMS
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END-USERS
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY TECHNIQUES
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY APPLICATIONS
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY MODEL ORGANISMS
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END-USERS
122. 6.122 REST OF MEA MARKET ANALYSIS BY TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY TECHNIQUES
124. 6.124 REST OF MEA MARKET ANALYSIS BY APPLICATIONS
125. 6.125 REST OF MEA MARKET ANALYSIS BY MODEL ORGANISMS
126. 6.126 REST OF MEA MARKET ANALYSIS BY END-USERS
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY TECHNIQUES, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY TECHNIQUES, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY APPLICATIONS, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY APPLICATIONS, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY MODEL ORGANISMS, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY MODEL ORGANISMS, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY END-USERS, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY END-USERS, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.2.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.2.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.2.5 BY END-USERS, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.3.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.3.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.3.5 BY END-USERS, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.4.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.4.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.4.5 BY END-USERS, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.5.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.5.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.5.5 BY END-USERS, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.6.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.6.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.6.5 BY END-USERS, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.7.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.7.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.7.5 BY END-USERS, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.8.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.8.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.8.5 BY END-USERS, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.9.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.9.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.9.5 BY END-USERS, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.10.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.10.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.10.5 BY END-USERS, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.11.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.11.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.11.5 BY END-USERS, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.12.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.12.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.12.5 BY END-USERS, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.13.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.13.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.13.5 BY END-USERS, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.14.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.14.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.14.5 BY END-USERS, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.15.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.15.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.15.5 BY END-USERS, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.16.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.16.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.16.5 BY END-USERS, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.17.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.17.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.17.5 BY END-USERS, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.18.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.18.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.18.5 BY END-USERS, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.19.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.19.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.19.5 BY END-USERS, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.20.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.20.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.20.5 BY END-USERS, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.21.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.21.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.21.5 BY END-USERS, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.22.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.22.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.22.5 BY END-USERS, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.23.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.23.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.23.5 BY END-USERS, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.24.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.24.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.24.5 BY END-USERS, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.25.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.25.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.25.5 BY END-USERS, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.26.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.26.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.26.5 BY END-USERS, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.27.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.27.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.27.5 BY END-USERS, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.28.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.28.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.28.5 BY END-USERS, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.29.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.29.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.29.5 BY END-USERS, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY TECHNIQUES, 2025-2035 (USD Billion)
  3. 7.30.3 BY APPLICATIONS, 2025-2035 (USD Billion)
  4. 7.30.4 BY MODEL ORGANISMS, 2025-2035 (USD Billion)
  5. 7.30.5 BY END-USERS, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

OCR gene gun
microinjections
electroporator

Healthcare By Techniques (USD Billion, 2025-2035)

retro-virus-mediated transfer of gene
embryonic stem cell-mediated transfer of gene
microinjection of DNA

Healthcare By Applications (USD Billion, 2025-2035)

recombinant human proteins
monoclonal antibodies
xenotransplantation

Healthcare By Model Organisms (USD Billion, 2025-2035)

Healthcare By End-Users (USD Billion, 2025-2035)

biotechnological industry
research organizations
academic institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”